SCHEMBL15565247

SCHEMBL15565247

Cc1ccc(C)c(P(=O)(O)c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.44
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
ACP3 P15309 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HCRTR1 O43613 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
CFTR P13569 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
PTK2B Q14289 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5605849 0.86 LMNA (0.48) TSHRLMNAHTTCA2CA4
SCHEMBL4401222 0.85 HPGD (0.48) TSHRLMNAHTTCA2CA4
SCHEMBL967941 0.85 LMNA (0.48) TSHRLMNAHTTACP3MEN1
SCHEMBL4401114 0.81 POLB (0.50) LMNAHTTKDM4EPOLBMAPT
SCHEMBL2473967 0.81 CA2 (0.48) TSHRLMNAHTTCA2CA4
SCHEMBL30598263 0.81 CA2 (0.48) TSHRLMNAHTTCA2CA4
SCHEMBL5605189 0.77 TSHR (0.82) TSHRLMNAHTTCA2CA4
SCHEMBL3353304 0.77 LMNA (0.43) TSHRLMNAHTTACP3MEN1
SCHEMBL25797392 0.74 HPGD (0.48) HTTCA2CA4CA5AKDM4E
SCHEMBL15717372 0.74 TSHR (0.47) TSHRLMNAHTTCA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2880041-B1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS COUNCIL SCIENT IND RES (IN) 2018-10-10 EP claimed
EP-2880041-B1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS COUNCIL SCIENT IND RES (IN) 2018-10-10 EP disclosed
US-9200018-B2 Process for preparation of aryl phosphorous compounds COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-12-01 US disclosed
US-20150210725-A1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-30 US disclosed
EP-2880041-A1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS Council of Scientific & Industrial Research (IN) 2015-06-10 EP disclosed
WO-2014024212-A1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210725-A1 PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS PFAS, PAICS, INPP5B TSHR 1819/4885LMNA 1804/4885HTT 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.